The crystallization and preliminary X-ray diffraction analysis of the catalytic domains of cell-surface-expressed chitinase ChiW from Paenibacillus sp. strain FPU-7 are reported.
Keywords: ChiW, cell-surface-expressed chitinase, Paenibacillus sp. strain FPU-7
Abstract
The polysaccharide chitin is effectively hydrolyzed and utilized as a carbon and nitrogen source by the Gram-positive bacterium Paenibacillus sp. strain FPU-7. ChiW is a unique cell-surface-expressed chitinase among the Paenibacillus sp. strain FPU-7-secreted chitinases. An N-terminally truncated ChiW protein, primarily comprised of the two catalytic domains of the full-length protein, was successfully overexpressed in Escherichia coli, purified as a functional recombinant protein with a molecular mass of approximately 98 kDa and crystallized. Preliminary X-ray analysis showed that the crystal diffracted to 1.93 Å resolution and belonged to the orthorhombic space group P212121, with unit-cell parameters a = 112.1, b = 128.2, c = 162.6 Å, suggesting the presence of two molecules in an asymmetric unit.
1. Introduction
The Gram-positive soil bacterium Paenibacillus sp. strain FPU-7 was reported to have a high degradation activity towards chitin (Itoh et al., 2013 ▶). It is noteworthy that ChiW was identified as a novel cell-surface-expressed multi-modular chitinase (Itoh et al., 2013 ▶). ChiW contains a signal peptide (amino acids 1–30) and three repeated surface-layer homology (SLH; amino acids 31–197) domains anchored to the bacterial surface layer (Mesnage et al., 2000 ▶; Schneewind & Missiakas, 2012 ▶; Fig. 1 ▶ a). The SLH domains are followed by two homologous catalytic domains (54% amino-acid sequence identity) belonging to the glycoside hydrolase family GH-18 chitinases (first GH-18, amino acids 557–927; second GH-18, amino acids 1045–1418; Itoh et al., 2014 ▶; http://www.cazy.org/; Henrissat & Bairoch, 1996 ▶; Fig. 1 ▶ a). The remaining regions, in particular amino acids 198–556, showed no sequence similarity to other known proteins. Although several chitinases with two catalytic domains in a single polypeptide chain have been identified in a wide variety of organisms (Tanaka et al., 1999 ▶; Howard et al., 2004 ▶; Hiramatsu et al., 1999 ▶), ChiW is the first chitinase that is expressed on the bacterial surface layer.
Figure 1.
Schematic representation of Paenibacillus sp. strain FPU-7 ChiW primary structure and SDS–PAGE analysis of purified ChiW-CD. (a) ChiW denotes full-length Paenibacillus sp. strain FPU-7 ChiW protein; ChiW-SLHd and ChiW-CD denote the truncated ChiW proteins. (b) SDS–PAGE protein profile of ChiW-CD. Lane M, molecular-weight standards (labelled in kDa); lane 1, purified ChiW-CD (1 µg).
A recombinant ChiW-SLHd construct (amino acids 198–1418; Fig. 1 ▶ a) lacking the SLH domains was purified from Escherichia coli cells and several of its enzymatic properties have been determined (Itoh et al., 2013 ▶, 2014 ▶). The detailed crystal structures of the catalytic domains (TIM-barrel) of GH-18 chitinases have been investigated (http://www.cazy.org/GH18_structure.html). However, to our knowledge, no information is currently available on the structures of the cell-surface-expressed multi-modular chitinases in the Protein Data Bank (PDB). Since crystallizations of full-length recombinant ChiW-SLHd protein have thus far been unsuccessful, we prepared the truncated mutant protein ChiW-CD (amino acids 557–1418; Fig. 1 ▶ a), which is primarily composed of two tandem catalytic GH-18 domains. Here, we report the crystallization and preliminary crystallographic analysis of ChiW-CD.
2. Materials and methods
2.1. Macromolecule production
The ChiW-SLHd gene (DDBJ/EMBL/GenBank database accession No. AB683965) was subcloned into the expression vector pColdIII (Takara, Otsu, Shiga, Japan) from Paenibacillus sp. strain FPU-7 genomic DNA as previously described (Itoh et al., 2013 ▶). Inverse PCR was used for constructing the truncated mutant ChiW-CD (Fig. 1 ▶ a) with a C-terminal 6×His tag using a KOD Plus mutagenesis kit (Toyobo, Osaka, Japan) and the expression vector for ChiW-SLHd as a template. Successful plasmid construction was confirmed by DNA sequencing with an ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems, Foster City, California, USA). The expression vector for ChiW-CD was transformed into competent E. coli BL21 cells (Novagen, Darmstadt, Germany; Table 1 ▶).
Table 1. ChiW-CD production information.
Source organism | Paenibacillus sp. strain FPU-7 |
DNA source | pColdIII_ChiW-SLHd expression vector with C-terminal 6×His tag |
Forward primer | 5′-CTCGAGGGTACCGAGCTCCATATGCAC-3′ |
Reverse primer | 5′-GTGCAGGGCAAAATTGTTTCTTATATCCCGGCTTG-3′ |
Expression vector | pColdIII |
Expression host | E. coli BL21 |
Recombinant ChiW-CD was purified from E. coli cells by the same procedure used for ChiW-SLHd with minor variations (Itoh et al., 2014 ▶). In brief, the cultured cells were chemically disrupted and the cell extract was subsequently purified by Ni-immobilized metal-affinity chromatography (HisTrap HP column; GE Healthcare, Little Chalfont, England) and anion-exchange chromatography (Mono Q HR 10/10 HR column; GE Healthcare). Enzyme-containing fractions were combined and dialyzed at 277 K overnight against 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer pH 7.0. The protein concentration was determined by UV spectrophotometry using the theoretical molar extinction coefficient ∊280 = 193 900 M −1 cm−1) according to the ExPASy ProtParam tool server (http://web.expasy.org/protparam/; Gasteiger et al., 2005 ▶). ChiW-CD was purified from the bacterial cells to homogeneity, as assessed by 12%(w/v) SDS–PAGE followed by Coomassie Brilliant Blue (CBB) R-250 staining.
2.2. Crystallization
Initial screening for ChiW-CD crystallization was performed using the commercially available crystallization kits Crystal Screen and Crystal Screen 2 (Hampton Research, Aliso Viejo, California, USA) and Wizard Classic Crystallization Screens 1 and 2 (Emerald BioSystems, Bedford, Massachusetts, USA) by the sitting-drop vapour-diffusion method in 96-well plates at 293 K. Crystallization conditions were further refined using a 24-well plate. Final crystal preparation was performed by the sitting-drop vapour-diffusion method. The drop (4 µl) consisted of 2 µl enzyme solution (10 mg ml−1) and 2 µl reservoir solution (0.5 ml) comprising 0.94 M ammonium phosphate, 0.1 M citrate–phosphate buffer (0.1 M citric acid and 0.2 M dibasic sodium phosphate solutions were mixed to adjust the pH to 5.5) (Table 2 ▶).
Table 2. Crystallization conditions.
Method | Sitting-drop vapour diffusion |
Plate type | 24-well plate |
Temperature (K) | 293 |
Protein concentration (mg ml−1) | 10 |
Buffer composition of protein solution | 20 mM HEPES pH 7.0 |
Composition of reservoir solution | 0.94 M ammonium phosphate, 0.1 M citrate–phosphate pH 5.5 |
Volume and ratio of drop | 4 µl, 1:1 enzyme solution:reservoir solution |
Volume of reservoir (µl) | 500 |
2.3. Data collection and processing
Single crystals were soaked in a cryoprotectant solution consisting of 0.27 M ammonium phosphate, 0.029 M citrate–phosphate pH 5.5, 5 M sodium formate followed by cooling in a stream of cold nitrogen gas. The diffraction patterns were then examined on beamlines BL38B1 at SPring-8 and BL-17A at the Photon Factory. X-ray diffraction data for the ChiW-CD crystals were collected using Quantum 315r CCD detectors (Area Detector Systems Corporation, Poway, California, USA) and were indexed, integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997 ▶). Molecular-replacement trials were performed using Phaser (McCoy et al., 2007 ▶) from the CCP4 software package (Winn et al., 2011 ▶) (Table 3 ▶).
Table 3. Data-collection statistics for ChiW-CD.
Values in parentheses are for the outer shell.
Diffraction source | BL-17A, Photon Factory |
Wavelength (Å) | 0.98 |
Temperature (K) | 95 |
Detector | Quantum 315r CCD |
Crystal-to-detector distance (mm) | 256.1 |
Rotation range per image (°) | 0.5 |
Total rotation range (°) | 180 |
Exposure time per image (s) | 5.0 |
Space group | P212121 |
Unit-cell parameters (Å) | a = 112.1, b = 128.2, c = 162.6 |
Mosaicity (°) | 0.453 |
Resolution range (Å) | 50.0–1.93 (1.96–1.93) |
Total No. of reflections | 1215285 |
No. of unique reflections | 174215 (8716) |
Completeness (%) | 98.9 (100) |
Multiplicity | 7.0 (6.8) |
〈I/σ(I)〉 | 29.7 (2.8) |
R meas † (%) | 8.6 (57.2) |
Overall B factor from Wilson plot (Å2) | 25.5 |
R
meas =
, where Ii (hkl) is the ith observation of reflection hkl and 〈I(hkl)〉 is the weighted average intensity for all i observations of reflection hkl.
3. Results and discussion
The overexpressed ChiW-CD in E. coli was successfully purified to homogeneity as observed by SDS–PAGE (Fig. 1 ▶ b). Other characteristics of ChiW-CD, such as enzymatic activity, N-terminal amino-acid residues and secondary-structural information evaluated from the far-UV circular-dichroism spectrum, are described in the Supporting Information1.
After incubation for 3 d, small crystals appeared in Wizard Classic 1 No. 9 condition consisting of 1.0 M ammonium phosphate, 0.1 M sodium acetate pH 4.5. Plate-like crystals were generated under the optimized condition of 0.94 M ammonium phosphate, 0.1 M citrate–phosphate buffer pH 5.5 (Table 2 ▶, Fig. 2 ▶). Several diffraction data sets were collected at the SPring-8 or Photon Factory synchrotron-radiation facilities. The highest quality X-ray diffraction data set was collected to 1.93 Å resolution on the BL-17A beamline of the Photon Factory (Fig. 3 ▶). A summary of the data-collection statistics is shown in Table 3 ▶. Based on a Matthews coefficient V M of 2.99 Å3 Da−1 (solvent content of 58.9%) we assume that two monomers exist in the asymmetric unit (Matthews, 1968 ▶). Initial molecular-replacement trials were performed with Phaser using the coordinates of Bacillus circulans WL-12 chitinase A1 catalytic domain (PDB entry 1itx; 42% sequence identity; Matsumoto et al., 1999 ▶) as the search model. Since ChiW-CD consists of two GH-18 catalytic domains (amino acids 557–927 and 1045–141; Fig. 1 ▶ a) and two molecules are proposed to exist in the asymmetric unit, four unambiguous solutions were generated (RFZ = 5.1, 4.2, 4.0 and 3.2; TFZ = 37.0; PAK = 40; LLG = 327). However, the entire polypeptide chain sequence could not be conclusively traced, except for the catalytic domains, because the electron densities of the remaining region (amino acids 928–1044; Fig. 1 ▶ a) were too low to identify the amino-acid structures.
Figure 2.
Crystals of ChiW-CD.
Figure 3.
X-ray diffraction image of ChiW-CD. The outer black circle corresponds to 1.8 Å resolution.
Supplementary Material
Supporting Information.. DOI: 10.1107/S2053230X14002325/no5046sup1.pdf
Acknowledgments
This study is part of the ‘High-Quality Protein Crystal Growth Experiment on JEM’ promoted by JAXA (Japan Aerospace Exploration Agency). The Russian space craft ‘Progress’ and ‘Soyuz’ provided by the Russian Federal Space Agency were used for space transportation. A part of the space crystallization technology was developed by the ESA (European Space Agency) and the University of Granada. We also thank Drs S. Baba, N. Mizuno, T. Hoshino and N. Miyano (SPring-8 beamline BL38B1) of the Japan Synchrotron Radiation Research Institute (JASRI) and the staff (Photon Factory beamline BL-17A) of the High Energy Accelerator Research Organization (KEK) for their help in data collection. The diffraction data were collected at the BL38B1 station of SPring-8 with the approval of JASRI (proposal Nos. 2011A1882, 2011A1990, 2012A1066, 2012B1148, 2013A1372 and 2013B1339) and at the BL-17A station of the Photon Factory (proposal No. 2011G674). This work was supported by a grant from FPU Promotion of Community Fund and by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese government. This work was also supported in part by a Grant-in-Aid for Young Scientists (B) (TI; grant No. 25850234) from the Japan Society for the Promotion of Science.
Footnotes
Supporting information has been deposited in the IUCr electronic archive (Reference: NO5046).
References
- Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D. & Bairoch, A. (2005). The Proteomics Protocols Handbook, edited by J. M. Walker, pp. 571–607. Totowa: Humana Press.
- Henrissat, B. & Bairoch, A. (1996). Biochem. J. 316, 695–696. [DOI] [PMC free article] [PubMed]
- Hiramatsu, S., Ishihara, M., Fujie, M., Usami, S. & Yamada, T. (1999). Virology, 260, 308–315. [DOI] [PubMed]
- Howard, M. B., Ekborg, N. A., Taylor, L. E. II, Weiner, R. M. & Hutcheson, S. W. (2004). J. Bacteriol. 186, 1297–1303. [DOI] [PMC free article] [PubMed]
- Itoh, T., Hibi, T., Fujii, Y., Sugimoto, I., Fujiwara, A., Suzuki, F., Iwasaki, Y., Kim, J.-K., Taketo, A. & Kimoto, H. (2013). Appl. Environ. Microbiol. 79, 7482–7490. [DOI] [PMC free article] [PubMed]
- Itoh, T., Sugimoto, I., Hibi, T., Suzuki, F., Taketo, A., Fujii, Y. & Kimoto, H. (2014). In the press. [DOI] [PMC free article] [PubMed]
- Matsumoto, T., Nonaka, T., Hashimoto, M., Watanabe, T. & Mitsui, Y. (1999). Proc. Jpn. Acad. Ser. B, 75, 269–274.
- Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
- McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. [DOI] [PMC free article] [PubMed]
- Mesnage, S., Fontaine, T., Mignot, T., Delepierre, M., Mock, M. & Fouet, A. (2000). EMBO J. 19, 4473–4484. [DOI] [PMC free article] [PubMed]
- Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. [DOI] [PubMed]
- Schneewind, O. & Missiakas, D. M. (2012). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 367, 1123–1139. [DOI] [PMC free article] [PubMed]
- Sreerama, N., Venyaminov, S. Y. & Woody, R. W. (1999). Protein Sci. 8, 370–380. [DOI] [PMC free article] [PubMed]
- Tanaka, T., Fujiwara, S., Nishikori, S., Fukui, T., Takagi, M. & Imanaka, T. (1999). Appl. Environ. Microbiol. 65, 5338–5344. [DOI] [PMC free article] [PubMed]
- Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information.. DOI: 10.1107/S2053230X14002325/no5046sup1.pdf